166 related articles for article (PubMed ID: 21039869)
1. Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs.
Rau SE; Barber LG; Burgess KE
J Vet Intern Med; 2010; 24(6):1452-7. PubMed ID: 21039869
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 May; 244(10):1164-9. PubMed ID: 24786163
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418
[TBL] [Abstract][Full Text] [Related]
4. Effects of maropitant, acepromazine, and electroacupuncture on vomiting associated with administration of morphine in dogs.
Koh RB; Isaza N; Xie H; Cooke K; Robertson SA
J Am Vet Med Assoc; 2014 Apr; 244(7):820-9. PubMed ID: 24649993
[TBL] [Abstract][Full Text] [Related]
5. Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
Kantyka ME; Meira C; Bettschart-Wolfensberger R; Hartnack S; Kutter APN
J Vet Emerg Crit Care (San Antonio); 2020 Jul; 30(4):436-441. PubMed ID: 32515910
[TBL] [Abstract][Full Text] [Related]
6. Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 Nov; 245(9):1015-20. PubMed ID: 25313812
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs.
Benchaoui HA; Siedek EM; De La Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Vet Rec; 2007 Sep; 161(13):444-7. PubMed ID: 17906225
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the administration of maropitant and loperamide to dogs with cancer for the prevention and reduction of adverse effects associated with the administration of paclitaxel.
Cartagena-Albertus JC; Engel Manchado J; Moise A; Moya García S; Montoya Alonso JA
Am J Vet Res; 2019 Jun; 80(6):601-606. PubMed ID: 31140850
[TBL] [Abstract][Full Text] [Related]
9. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
Kenward H; Elliott J; Lee T; Pelligand L
BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.
Ramsey DS; Kincaid K; Watkins JA; Boucher JF; Conder GA; Eagleson JS; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):538-43. PubMed ID: 19000277
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone.
Hay Kraus BL
Vet Anaesth Analg; 2013 Jan; 40(1):28-34. PubMed ID: 23082784
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study.
Mason SL; Grant IA; Elliott J; Cripps P; Blackwood L
J Small Anim Pract; 2014 Aug; 55(8):391-8. PubMed ID: 24920169
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.
Conder GA; Sedlacek HS; Boucher JF; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):528-32. PubMed ID: 19000275
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of adverse events in small-breed dogs treated with maropitant and a single dose of doxorubicin.
Matsuyama F; Harada K; Fukazawa E; Ichimata M; Nakano Y; Kobayashi T
J Vet Intern Med; 2022 Jul; 36(4):1409-1415. PubMed ID: 35524687
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine.
Lorenzutti AM; Martín-Flores M; Litterio NJ; Himelfarb MA; Zarazaga MP
Vet Anaesth Analg; 2016 Mar; 43(2):195-8. PubMed ID: 26095960
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
Yalcin E; Keser GO
J Vet Pharmacol Ther; 2017 Dec; 40(6):599-603. PubMed ID: 28198032
[TBL] [Abstract][Full Text] [Related]
17. Effects of maropitant citrate or acepromazine on the incidence of adverse events associated with hydromorphone premedication in dogs.
Claude AK; Dedeaux A; Chiavaccini L; Hinz S
J Vet Intern Med; 2014; 28(5):1414-7. PubMed ID: 25146756
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.
Sedlacek HS; Ramsey DS; Boucher JF; Eagleson JS; Conder GA; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):533-7. PubMed ID: 19000276
[TBL] [Abstract][Full Text] [Related]
19. The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
de la Puente-Redondo VA; Siedek EM; Benchaoui HA; Tilt N; Rowan TG; Clemence RG
J Small Anim Pract; 2007 Feb; 48(2):93-8. PubMed ID: 17286662
[TBL] [Abstract][Full Text] [Related]
20. The effect of maropitant on intraoperative isoflurane requirements and postoperative nausea and vomiting in dogs: a randomized clinical trial.
Swallow A; Rioja E; Elmer T; Dugdale A
Vet Anaesth Analg; 2017 Jul; 44(4):785-793. PubMed ID: 28844293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]